Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids

Acta Biologica Hungarica

Volumn 58, Issue SUPPL. 1, 2007, Pages 113-129

  Páldyová, Estera ^a   Bereczki, E ^a   Santha M ^a   Wenger, T ^b   Borsodi, Anna ^a   Benyhe, S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

35S GTP S binding; Cannabinoid receptors; CB1 receptor knockout mouse; Cerebellum; Noladin ether; Opioid receptors; Real time PCR; Rimonabant; SR144528

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; OPIATE RECEPTOR; PRIMER DNA;

ANIMAL; ARTICLE; CEREBELLUM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CANNABINOIDS; CEREBELLUM; DNA PRIMERS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID;

ANIMALIA; CANNABIS; EPICOCCUM; MUS; MUS MUSCULUS;

EID: 38749139237     PISSN: 02365383     EISSN: 1588256X     Source Type: Journal    
DOI: 10.1556/ABiol.58.2007.Suppl.9     Document Type: Article

References (58)

1. Abeyta, A., Dettmer, T. S., Barnes, A., Vega, D., Carta, M., Gallegos, N., Raymond-Stintz, M., Savage, D. D., Valenzuela, C. F., Saland, L. C. (2002) Delta opioid receptor localization in the rat cerebellum. Brain Res. 931, 100-105.
2. 7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain. J. Neurosci. Res. 48, 249-258.
3. 3H]ethylketocyclazocine. Life Sci. 51, 1647-1655.
4. 7 binding to multiple sites in rat and guinea pig cerebellum. Life Sci. 64, 1189-1196.
5. Blackburn, T. P., Cross, A. J., Hille, C., Slater, P. (1988) Autoradiographic localization of delta opiate receptors in rat and human brain. Neuroscience 27, 497-506.
6. Childers, S. R., Fleming, L., Konkoy, C., Marckel, D., Pacheco, M., Sexton, T., Ward, S. (1992) Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Ann. NY Acad. Sci. 654, 33-51.
7. Clarke, S., Kitchen, I. (1999) Opioid analgesia: new information from gene knockout studies. Curr. Opin. Anaesthesiol. 5, 609-614.
8. Corchero, J., Avila, M. A., Fuentes, J. A., Manzanares, J. (1997a) Delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. Life Sci. 61, 39-43.
9. Corchero, J., Fuentes, J. A., Manzanares, J. (1997b) Delta-9- Tetrahydrocannabinol increases pro-opiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. Eur. J. Pharmacol. 323, 193-195.
10. De Petrocellis, L., Di Marzo, V. (2005) Lipids as regulators of the activity of transient receptor potential type VI (TRPV1) channels. Life Sci. 77, 1651-1666.
11. Delfs, J. M., Kong, H., Mestek, A., Chen, Y., Yu, L., Reisine, T., Chesselet, M. F. (1994) Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 345, 46-68.
12. Demuth, D. G., Molleman, A. (2006) Cannabinoid signaling. Life Sci. 78, 549-563.
13. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
14. Dhawan, B. N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S., Hamon, M. (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48, 567-592.
15. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., Leona, A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92, 3376-3380.
16. Fields, H. L., Meng, I. D. (1998) Watching the pot boil. Nat. Med. 4, 1008-1009.
17. Galiègue, S., Mary, S., Marhand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human tissues and leukocytes subpopulations. Eur. J. Biochem. 232, 54-61.
18. Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., Uhl, G. R. (2006) Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res. 1071, 10-23.
19. Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., Mechoulam, R. (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA 98, 3662-3665.
20. Hájos, N., Ledent, C., Freund, T. F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106, 1-4.
21. Herráez-Baranda, L., Carretero, J., González-Sarmiento, R., Rodríguez, R. E. (2005) Kappa opioid receptor is expressed in the rat cerebellar cortex. Cell Tissue Res. 320, 223-228.
22. Howlett, A. C. (1995) Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol. 35, 607-634.
23. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R., Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202.
24. Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., Malan, T. P. Jr (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. USA 102, 3093-3098.
25. Kieffer, B. L. (1999) Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20, 19-26.
26. 1 receptor knockout mice. Science 283, 401-404.
27. Maldonado, R., Rodríguez de Fonseca, F. (2002) Cannabinoid addiction: behavioral models and neuronal correlates. J. Neurosci. 22, 3326-3331.
28. Mansour, A., Fox, C. A., Akil, H., Watson, S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
29. Mansour, A., Khachaturian, A., Lewis, M. E., Akil, H., Watson, S. J. (1988) Anatomy of CNS opioid receptors Trends Neurosci. 11, 308-314.
30. Manzanares, J., Corchero, J., Romero, J. J., Fernandez-Ruiz, J. J., Ramos, J. A., Fuentes, J. A. (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20, 287-293.
31. Manzanares, J., Ortiz, S., Oliva, J. M., Perez-Rial, S., Palomo, T. (2005) Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects. Alcohol Alcohol. 40, 25-34.
32. Matsuda, L. A., Lolait, S. J., Brownstein, B. J., Young, A. C., Bonner, T. L. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
33. Matthes, H. W., Smadja, C., Valverde, O., Vonesch, J. L., Foutz, A. S., Boudinot, E., Denavit-Saubie, M., Severini, C., Negri, L., Roques, B. P., Maldonado, R., Kieffer, B. L. (1998) Activity of the deltaopioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J. Neurosci. 18, 7285-7295.
34. Meunier, J. C., Kouakou, Y., Puget, A., Moisand, C. (1983) Multiple opiate binding sites in the central nervous system of the rabbit: Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Mol. Pharmacol. 24, 23-29.
35. Monory, K., Tzavara, E. Th., Lexime, J., Ledent, C., Parmentier, M., Borsodi, A., Hanoune, J. (2002) Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochem. Biophys. Res. Commun. 292, 231-235.
36. Mrkusich, E. M., Kivell, B. M., Miller, J. H., Day, D. J. (2004) Abundant expression of mu and delta opioid receptor mRNA and protein in the cerebellum of the fetal, neonatal, and adult rat. Develop. Brain Res. 148, 213-222.
37. Munro, S., Thomas, K. L., Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
38. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29, e45.
39. Peckys, D., Landwehrmeyer, G. B. (1999) Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience 88, 1093-1135.
40. 35S] guanylyl-5′-O-(γ-thio)-triphosphate binding in human frontal cortex and cerebellum. Neuroscience Letters 283, 212-216.
41. Puskas, L. G., Bereczki, E., Santha, M., Vigh, L., Csanadi, G., Spener, F., Ferdinandy, P., Onody, A. and others (2005) Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain. Biochimie 87, 817-824.
42. Reisine, T., Law, S. F., Blake, A., Tallent, M. (1996) Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Ann. NY Acad. Sci. 780, 168-175.
43. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J. C., LeFur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350, 240-244.
44. Robson, L. E., Foote, R. W., Mauer, R., Kosterlitz, H. W. (1984) Opioid binding sites of the kappa-type in guinea-pig cerebellum. Neuroscience 12, 621-627.
45. 1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus. J. Neurosci. 21, 823-833.
46. Saab, C. Y., Willis, W. D. (2003) The cerebellum: organization, functions and its role in nociception. Brain Res. Rev. 42, 85-95.
47. Saland, L. C., Abeyta, A., Frausto, S., Raymond-Stintz, M., Hastings, C. M., Carta, M. Valenzuela, C. F., Savage, D. D. (2004) Chronic ethanol consumption reduces delta- and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcohol Clin. Exp. Res. 28, 98-104.
48. Samson, M. T., Small-Howard, A., Shimoda, L. M. N., Koblan-Huberson, M., Stokes, A. J., Turner, H. (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J. Immunol. 170, 4953-4962.
49. Shapira, M., Vogel, Z., Sarne, Y. (2000) Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells with endogenously coexpress the receptors. Cell. Mol. Neurobiol. 20, 291-304.
50. 35] guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386, 562-572.
51. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92, 7242-7246.
52. Skaper, S. D., Buriani, A., Dal Toso, R., Petrelli, L., Romanello, S., Facci, L., Leon, A. (1996) The ALIAmide palmitoylethanolamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebral granule neurons. Proc. Natl. Acad. Sci. USA 93, 3984-3989.
53. 35S](thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharm. 47, 848-854.
54. 2 receptors. Science 310, 329-332.
55. Vasques, C., Lewis, L. D. (1999) The CB1 cananbinoid receptor can sequester G proteins, making them unavailable to couple to other receptors. J. Neurosci. 19, 9271-9280.
56. Vigano, D., Grazia Cascio, M., Rubino, T., Fezza, F., Vaccani, A., DiMarzo, V., Parolaro, D. (2003) Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28, 1160-1167.
57. Zhang, Y., Pan, Y. X., Kolesnikov, Y., Pasternak, G. W. (2006) Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system. Brain Res. 1099, 33-43.
58. Zimmer, A., Zimmer, A. G., Hohmann, A. G., Herkenham, M., Bonner, T. I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96, 5780-5785.